Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methylhydrazine | HCID 6061 | — |
| Reactant | HCID 19917874 | HCID 19917874 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 19917863 | HCID 19917863 | 98% |
Reaction Steps
1-[(7-Bromo-4-chloro-2,2-diphenyl-1,3-benzodioxol-5-yl)carbonyl]-2-[2-methyl-2-(phthalimidooxy)propionyl]hydrazine 500 mg (0.77 mmol) are dissolved in 10 ml of tetrahydrofuran and treated at 0° C. with 35 mg (0.77 mmol) of methylhydrazine. After stirring at 0° C. for 2 hours and stirring at room temperature for 3 hours the mixture is concentrated in a vacuum. The residue is chromatographed on 20 g of silica gel (0.06-02 mm). The product is eluted with dichloromethane/ethanol (95:5 v/v). The eluate is concentrated and the residue is treated with ethanolic hydrochloric acid. After crystallization from ethanol/diethyl ether there are obtained 220 mg of 1-[2-(aminooxy)-2-methylpropionyl]-2-[(7-bromo-4-chloro-2,2-diphenyl-1,3-benzodioxol-5-yl)carbonyl]hydrazine hydrochloride (1:1) as white crystals of melting point 216°-218° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05438052 |
|---|
| Source dataset | uspto-grants-1995_08 |
|---|
| ORD ID | ord-bcbb8355103444f7af793fff6e6aca16 |
|---|
| Source note | uspto-grants-1995_08 |
|---|